These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18977481)

  • 1. Why to screen heart disease in diabetes.
    Fadini GP; de Kreutzenberg SV; Tiengo A; Avogaro A
    Atherosclerosis; 2009 May; 204(1):11-5. PubMed ID: 18977481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silent myocardial ischaemia. To screen or not to screen? That is..
    Valensi P
    Arch Cardiovasc Dis; 2008 Sep; 101(9):509-11. PubMed ID: 19041833
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening guidelines for coronary heart disease in diabetes: current recommendations.
    Singh S; Duggal J; Khosla N; Arora R
    J Cardiometab Syndr; 2009; 4(2):107-12. PubMed ID: 19614798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure and nephropathy: catastrophic and interrelated complications of diabetes.
    Gilbert RE; Connelly K; Kelly DJ; Pollock CA; Krum H
    Clin J Am Soc Nephrol; 2006 Mar; 1(2):193-208. PubMed ID: 17699208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure and diabetes.
    Bala C; Hâncu N
    Rom J Intern Med; 2004; 42(2):267-75. PubMed ID: 15529617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should diabetes still be considered a coronary artery disease equivalent?
    Magri CJ; Fava S
    J Cardiovasc Med (Hagerstown); 2012 Nov; 13(11):760-5. PubMed ID: 22885535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.
    Naghavi M; Falk E; Hecht HS; Jamieson MJ; Kaul S; Berman D; Fayad Z; Budoff MJ; Rumberger J; Naqvi TZ; Shaw LJ; Faergeman O; Cohn J; Bahr R; Koenig W; Demirovic J; Arking D; Herrera VL; Badimon J; Goldstein JA; Rudy Y; Airaksinen J; Schwartz RS; Riley WA; Mendes RA; Douglas P; Shah PK;
    Am J Cardiol; 2006 Jul; 98(2A):2H-15H. PubMed ID: 16843744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Silent myocardial ischemia in diabetic patients: to screen or not to screen?].
    Meyer P
    Rev Med Suisse; 2005 Jun; 1(22):1505-7, 1509-10. PubMed ID: 16025890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renal patient with coronary artery disease: current concepts and dilemmas.
    Gupta R; Birnbaum Y; Uretsky BF
    J Am Coll Cardiol; 2004 Oct; 44(7):1343-53. PubMed ID: 15464310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening asymptomatic diabetic patients for coronary artery disease: why not?
    Miller TD; Redberg RF; Wackers FJ
    J Am Coll Cardiol; 2006 Aug; 48(4):761-4. PubMed ID: 16904546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery.
    Bauer SM; Cayne NS; Veith FJ
    J Vasc Surg; 2010 Jan; 51(1):242-51. PubMed ID: 19954922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress testing in patients with diabetes mellitus: diagnostic and prognostic value.
    Albers AR; Krichavsky MZ; Balady GJ
    Circulation; 2006 Jan; 113(4):583-92. PubMed ID: 16449735
    [No Abstract]   [Full Text] [Related]  

  • 13. Coronary artery calcium scanning: a useful tool for refining heart failure risk prediction?
    Latif MA; Budoff MJ
    Future Cardiol; 2013 Jan; 9(1):1-3. PubMed ID: 23259469
    [No Abstract]   [Full Text] [Related]  

  • 14. Noninvasive Cardiovascular Risk Assessment of the Asymptomatic Diabetic Patient: The Imaging Council of the American College of Cardiology.
    Budoff MJ; Raggi P; Beller GA; Berman DS; Druz RS; Malik S; Rigolin VH; Weigold WG; Soman P;
    JACC Cardiovasc Imaging; 2016 Feb; 9(2):176-92. PubMed ID: 26846937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetes mellitus, left ventricular dysfunction and congestive heart failure].
    Tarantini L; Di Lenarda A; Velussi M; Faggiano P; Comaschi M; Faglia E; Maggioni AP
    Ital Heart J Suppl; 2004 Aug; 5(8):605-15. PubMed ID: 15554015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and treatment by the primary care provider of common diabetes complications.
    Gilbert MP
    Med Clin North Am; 2015 Jan; 99(1):201-19. PubMed ID: 25456651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive cardiovascular risk factors therapy and prevalence of silent myocardial ischaemia in patients with type 2 diabetes.
    Barthelemy O; Jacqueminet S; Rouzet F; Isnard R; Bouzamondo A; Le Guludec D; Grimaldi A; Metzger JP; Le Feuvre C
    Arch Cardiovasc Dis; 2008 Sep; 101(9):539-46. PubMed ID: 19041838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of coronary artery calcium screening in subjects with and without diabetes.
    Raggi P; Shaw LJ; Berman DS; Callister TQ
    J Am Coll Cardiol; 2004 May; 43(9):1663-9. PubMed ID: 15120828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: Left ventricular dysfunction and heart failure in metabolic syndrome and diabetes without overt coronary artery disease--do we need to screen our patients?
    Roberts AW; Clark AL; Witte KK
    Diab Vasc Dis Res; 2009 Jul; 6(3):153-63. PubMed ID: 20368207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk in the young type 1 diabetes population with a low 10-year, but high lifetime risk of cardiovascular disease.
    McVeigh GE; Gibson W; Hamilton PK
    Diabetes Obes Metab; 2013 Mar; 15(3):198-203. PubMed ID: 22998614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.